4//SEC Filing
6 Dimensions Capital, L.P. 4
Accession 0001104659-19-041307
CIK 0001680581other
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 4:32 PM ET
Size
8.4 KB
Accession
0001104659-19-041307
Insider Transaction Report
Form 4
6 Dimensions Capital, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2019-07-22+441,071→ 441,071 total - Purchase
Common Stock
2019-07-22$16.00/sh+118,750$1,900,000→ 559,821 total - Conversion
Series B Preferred Stock
2019-07-22−3,087,500→ 0 total→ Common Stock (441,071 underlying)
Footnotes (1)
- [F1]On July 22, 2019 the Series B Preferred Stock converted into Common Stock on 7:1 basis upon the closing of the issuer's initial public offering without payment of consideration. The shares had no expiration date.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001717958
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 4:32 PM ET
- Size
- 8.4 KB